Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Non-Current Assets: 2016-2025

Historic Other Non-Current Assets for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to $730,043.

  • AC Immune's Other Non-Current Assets rose 52.41% to $730,043 in Q3 2025 from the same period last year, while for Sep 2025 it was $730,043, marking a year-over-year increase of 52.41%. This contributed to the annual value of $730,043 for FY2025, which is N/A change from last year.
  • As of FY2025, AC Immune's Other Non-Current Assets stood at $730,043, which was up 154,004.87% from $473.73 recorded in FY2024.
  • AC Immune's Other Non-Current Assets' 5-year high stood at $730,043 during FY2025, with a 5-year trough of $406.97 in FY2023.
  • In the last 3 years, AC Immune's Other Non-Current Assets had a median value of $473.73 in 2024 and averaged $243,641.
  • As far as peak fluctuations go, AC Immune's Other Non-Current Assets crashed by 99.89% in 2023, and later rose by 16.40% in 2024.
  • AC Immune's Other Non-Current Assets (Yearly) stood at $397,248 in 2021, then declined by 5.67% to $374,726 in 2022, then tumbled by 99.89% to $406.97 in 2023, then increased by 16.40% to $473.73 in 2024, then reached $730,043 in 2025.